Your search for major depressive disorder returned 15 results

In order to assess asymptomatic infections and immunologic responses to COVID-19, a team of researchers tested for SARS-CoV-2 antibodies in a multiple sclerosis cohort.

Study investigators sought to determine if galcanezumab would reduce not only the frequency of migraine days but also the disabling nonpain symptoms of episodic and chronic migraine.

Longitudinal changes in the dopamine transporter availability may identify patients with idiopathic REM sleep behavior disorder who are at risk of conversion to neurodegenerative diseases.

Proinflammatory cytokines, tryptophan catabolites, and the gut-brain axis may have key roles in chronic fatigue and depression in patients with multiple sclerosis.

Analysis of the HARMONY trial was conducted to evaluate the prevention of relapse in patients with dementia-related psychosis who have been treated with pimavanserin.

In early Parkinson Disease, fatigue, excessive daytime sleepiness, and emotional apathy are predictive of increasing fatigue severity.

Depression has been linked to elevated markers of inflammation, and aspirin, a nonsteroid, anti-inflammatory medication, can irreversibly inhibit cyclooxygenase-1 and 2.

Children who receive a depression diagnosis in their primary school age have a substantially higher risk of a depression relapse during adolescence compared with children who did not receive a depression diagnosis during their primary school age.

Convergent abnormalities were observed in secondary analyses across portions of the amygdala, hippocampus, subgenual cingulate cortex, and putamen.

Various migraine subgroups based on comorbidities can predict the risk for the progression of episodic migraine to chronic migraine.

The presence of psychiatric disorders in patients with idiopathic intracranial hypertension is associated with poor treatment outcomes.

Computerized cognitive training significantly improved global cognitive function in patients with subcortical vascular cognitive impairment.

Investigators predicted the prevalence of depressive symptoms among mothers over the first 10 years after their children were diagnosed with epilepsy and identified trajectories of maternal depressive symptoms over time and baseline characteristics related to each trajectory.

Investigators assessed demographic and epilepsy-specific factors independently associated with anxiety, including lesions and seizure focus localization.

Investigators aim to facilitate early recognition and consideration for patients with Duchenne muscular dystrophy and internalizing psychiatric symptoms.